Literature DB >> 8456433

A role for von Willebrand factor proline residues 702-704 in ristocetin-mediated binding to platelet glycoprotein Ib.

H Azuma1, M Sugimoto, Z M Ruggeri, J Ware.   

Abstract

Mutant domains of von Willebrand factor (vWF) were constructed to determine the effects of altering net charge, and presumably conformation, within a peptide sequence (residues 694-708) previously shown to be involved in the platelet receptor glycoprotein (GP) Ib binding function of vWF. Non-conservative substitutions replaced a triplet of proline residues (proline702-704) with either a triplet of arginine (positively-charged) or aspartic acid (negatively-charged) residues. After establishing stable CHO cell transformants, we observed the secretion of covalently-linked dimeric molecules analogous to a domain with native sequence. Functional assays using immunopurified molecules revealed that the ristocetin-dependent binding to GP Ib was abolished with both charge mutants. However, in the absence of disulfide-bond dependent conformation both mutant molecules and the molecule with native sequence interacted with GP Ib. The results demonstrate that vWF proline702-704 are important for the ristocetin-mediated interaction between vWF and GP Ib, but are not essential residues of the GP Ib binding site within vWF.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8456433

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  7 in total

1.  N-terminal flanking region of A1 domain in von Willebrand factor stabilizes structure of A1A2A3 complex and modulates platelet activation under shear stress.

Authors:  Matthew Auton; Katie E Sowa; Molly Behymer; Miguel A Cruz
Journal:  J Biol Chem       Date:  2012-03-19       Impact factor: 5.157

2.  Limitations of the ristocetin cofactor assay in measurement of von Willebrand factor function.

Authors:  V H Flood; K D Friedman; J C Gill; P A Morateck; J S Wren; J P Scott; R R Montgomery
Journal:  J Thromb Haemost       Date:  2009-08-19       Impact factor: 5.824

3.  Crystal structure of a platelet-agglutinating factor isolated from the venom of Taiwan habu (Trimeresurus mucrosquamatus).

Authors:  Kai-Fa Huang; Tzu-Ping Ko; Chin-Chun Hung; John Chu; Andrew H-J Wang; Shyh-Horng Chiou
Journal:  Biochem J       Date:  2004-03-01       Impact factor: 3.857

4.  Destabilization of the A1 domain in von Willebrand factor dissociates the A1A2A3 tri-domain and provokes spontaneous binding to glycoprotein Ibalpha and platelet activation under shear stress.

Authors:  Matthew Auton; Katie E Sowa; Scott M Smith; Erik Sedlák; K Vinod Vijayan; Miguel A Cruz
Journal:  J Biol Chem       Date:  2010-05-24       Impact factor: 5.157

5.  Promotion of binding of von Willebrand factor to platelet glycoprotein Ib by dimers of ristocetin.

Authors:  M F Hoylaerts; K Nuyts; K Peerlinck; H Deckmyn; J Vermylen
Journal:  Biochem J       Date:  1995-03-01       Impact factor: 3.857

6.  Platelet adhesion involves a novel interaction between vimentin and von Willebrand factor under high shear stress.

Authors:  Qi Da; Molly Behymer; Juliana I Correa; K Vinod Vijayan; Miguel A Cruz
Journal:  Blood       Date:  2014-03-18       Impact factor: 22.113

Review 7.  Recombinant von Willebrand factor: potential therapeutic use.

Authors:  B E Fischer
Journal:  J Thromb Thrombolysis       Date:  1999-10       Impact factor: 5.221

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.